Acumen Pharmaceuticals (ABOS) P/E (2021 - 2026)
Acumen Pharmaceuticals (ABOS) P/E from Sep 30, 2021 to Jul 20, 2026. The TTM Acumen Pharmaceuticals (ABOS) P/E is -1.22. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Acumen Pharmaceuticals (ABOS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.22 | +15.61% |
| 2025 | -1.05 | +4.29% |
| 2024 | -1.01 | -78.72% |
| 2023 | -4.75 | -44.16% |
| 2022 | -8.50 | -74.47% |
| 2021 | -33.28 | N/A |
Comparison Acumen Pharmaceuticals (ABOS) P/E with competitors
Acumen Pharmaceuticals (ABOS) P/E is -1.22.